Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?
- 31 August 1989
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 9 (2), 184-189
- https://doi.org/10.1016/0168-8278(89)90049-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver diseaseLiver International, 2008
- Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patientsDigestive Diseases and Sciences, 1986
- Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitisGastroenterology, 1986
- Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overloadHepatology, 1985
- Long-Term Follow-Up of Serum N-Terminal Propeptide of Collagen Type III Levels in Patients with Chronic Liver DiseaseHepatology, 1984
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver DiseaseHepatology, 1984
- Diagnostic Value of Serum Procollagen Peptide Measurements in Alcoholic Liver DiseaseAlcohol: Clinical and Experimental Research, 1984
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Biosynthesis of ProcollagenAnnual Review of Biochemistry, 1978